Cameron Gray - Director, Cue Biopharma, Inc

As of June 16, 2022


What is Cameron Gray's Net Worth?

The current estimated net worth of Cue Biopharma, Inc's Director, Cameron Gray, is estimated to be about $2.66M . Cameron Gray owns about 677,500 units of Cue Biopharma, Inc common stock. In the last 4 years at Cue Biopharma, Inc, Cameron Gray has sold an estimated value of $165K worth.

What is Cameron Gray's Past Insider Trading?

Cameron Gray's largest purchase order was 10,000 units , worth over $151.5K on October 1, 2020. In total, Cameron Gray has made about 8 transactions over 4 years of their time at Cue Biopharma, Inc. Cameron Gray usually trades in January, with the busiest year in 2022, 2019 and 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Cameron Gray's' Mailing Address?

  • Mailing address is 21 Erie Street Cambridge MA 02139 MA

What are Cue Biopharma, Inc's Past Insider Trades?

Cue Biopharma, Inc's most recent insider trade came on May 31, 2022 by Frank Morich who bought 28,000 units worth $105K . In the last 5 years, insiders at Cue Biopharma, Inc have sold an estimated value of $4.87M and bought an estimated value of $6.71M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Anish Suri, PRESIDENT AND CSO,  Christopher Marlett, Director,  and Daniel Passeri, CHIEF EXECUTIVE OFFICER .

Cue Biopharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1